Dale A. Sander - Aug 27, 2024 Form 4 Insider Report for Humacyte, Inc. (HUMA)

Role: CFO and Chief Corp. Deve. Off.
Signature: /s/ Dale A. Sander
Stock symbol: HUMA
Transactions as of: Aug 27, 2024
Transactions value $: -$162,283
Form type: 4
Date filed: 8/29/2024, 06:45 PM
Previous filing: Dec 12, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HUMA	Common Stock	Options Exercise	$101K	+39.4K	+1969.45%	$2.56	41.4K	Aug 27, 2024	Direct
transaction	HUMA	Common Stock	Sale	-$263K	-39.4K	-95.17%	$6.68	2K	Aug 27, 2024	Direct	F1
holding	HUMA	Common Stock						20.6K	Aug 27, 2024	By spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	HUMA	Stock Options (right to buy)	Options Exercise	$0	-39.4K	-100%	$0.00	0	Aug 27, 2024	Common Stock	39.4K	$2.56	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $6.67 to $6.725. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.